Generate Biomedicines Inc. (GENB) Live Share Price, Invest From India

Generate Biomedicines Inc. Stock Performance

as on August 12, 2026 at 4:06 am IST

Day's Low
Day's High
$14.17
Day's Price Range
$14.63
$14.41
1.67%
Downside
1.53%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$14.41
100.00%
Downside
-100.00%
Upside

Generate Biomedicines Inc. share price movements today

Previous Close: $14.72
Open: $14.53
Volume: 381.6K
Day's Low - High: $14.17 - $14.63

Generate Biomedicines Inc. Historical Returns

1 Month Return: + 2.76 %
3 Month Return: + 2.44 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Generate Biomedicines Inc. Stock Fundamentals & Key Indicators

Check Generate Biomedicines Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8B

EPS (TTM)

-2.3533

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-81.72%

Generate Biomedicines Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Generate Biomedicines Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Generate Biomedicines Inc.	NA	$1.8B	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$44.0B	669.41%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$125.7B	168.33%	28.91	35.00%	NA
Regeneron Pharmaceuticals Inc.	BUY	$80.8B	32.8%	19.42	27.87%	0.47000000000000003%

Indian Investors' Interest in Generate Biomedicines Inc. Stock

Search interest for Generate Biomedicines Inc. Stock has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 12, 2026 to August 11, 2026

Change:-53% versus previous 30 day period

Generate Biomedicines Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2025	Jun 2025	Mar 2026	Jun 2026
Total Revenue	8	10	7	6
Gross Profit	-	-	3	-
Operating Income	-48	-60	-64	-71
EBITDA	-	-	-60	-
Interest Expense	0	0	0	0
Depreciation	3	3	3	3
Income Before Tax	-44	-56	-61	-67
Income Tax Expense	-	-	0	-
Net Income	-41	-52	-61	-67
Net Profit Margin	-472.73%	-517.56%	-850.58%	-1065.17%

Generate Biomedicines Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2024	Dec 2025
Total Revenue	20	31
Gross Profit	20	31
Operating Income	-196	-235
EBITDA	-163	-208
Interest Expense	2	1
Depreciation	15	13
Income Before Tax	-181	-222
Income Tax Expense	0	0
Net Income	-173	-203
Net Profit Margin	-849.36%	-636.99%

Generate Biomedicines Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2025	Mar 2026	Jun 2026
Net Income	-52	-61	-67
Operating Cash Flow	-48	-80	-57
Investing Cash Flow	-	-252	-
Financing Cash Flow	0	371	0
Change in Cash	-66	160	-25

Generate Biomedicines Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2025
Net Income	-222
Operating Cash Flow	-200
Investing Cash Flow	116
Financing Cash Flow	28
Change in Cash	-55

Global Institutional Holdings in Generate Biomedicines Inc.

Funds	Holdings
BRAIDWELL LP	2.8%
JPMorgan Chase & Co	2.3%
T. Rowe Price Associates, Inc.	1.64%
NVIDIA Corp	0.65%
Sphera Funds Management Ltd.	0.14%

See all

Insights on Generate Biomedicines Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, GENB stock has moved up by 3.1%

About Generate Biomedicines Inc.

Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses protein-based modalities for drug development. Its product includes GB-0895, is an investigational long-acting anti-TSLP monoclonal antibody in development for severe asthma that is intended to be dosed every six months; GB-4362, an MMAE payload neutralizer monoclonal antibody; GB-5267, A MUC16 CAR-T Cell therapy. In additional, it develops Generate Platform, designed to be a therapeutic area and protein modality agnostic system integrating computational innovation with scalable biohardware to address therapeutic challenges beyond the reach of traditional technologies. Generate Biomedicines, Inc. was formerly known as Generate Biologics, Inc. and changed its name to Generate Biomedicines, Inc. in February 2020. The company was incorporated in 2018 and is based in Somerville, Massachusetts.

Organisation	Generate Biomedicines Inc.
Headquarters	101 South Street, Somerville, MA, United States, 02143
Industry	Biotechnology
CEO	Mr. Michael T. Nally M.B.A.
E-voting on shares	Click here to vote

Key Management of Generate Biomedicines Inc.

Name	Title
Mr. Sean B. W. Martin J.D.	Secretary, Chief Legal Officer & General Counsel
Dr. Daria Hazuda Ph.D.	Senior Vice President of Discovery Strategy
Dr. Noubar B. Afeyan Ph.D.	Co-founder & Independent Chair of the Board
Dr. Aarif Khakoo M.B.A., M.D.	Chief Scientific Officer
Dr. Gevorg Grigoryan Ph.D.	Co-Founder & CTO
Ms. Molly Gibson Ph.D.	Co-Founder
Ms. Beth Grous	Chief People Officer
Mr. Sahm Nasseri M.B.A.	Senior Vice President of Business Development & Strategy
Mr. Michael T. Nally M.B.A.	CEO & Director
Dr. Jason E. Silvers J.D., M.D.	President & CFO

FAQs

What is Generate Biomedicines Inc. share price today?

Generate Biomedicines Inc. share price today is $14.41 as on August 11, 2026 at 10:36 pm IST. Generate Biomedicines Inc. share today touched a day high of $14.63 and a low of $14.17.

What is the 52 week high and 52 week low for Generate Biomedicines Inc. share?

Generate Biomedicines Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Generate Biomedicines Inc. stock price today i.e. August 11, 2026 at 10:36 pm IST is trending at $14.41,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Generate Biomedicines Inc.'s market capitalisation today?

Generate Biomedicines Inc. market capitalisation is $0.00T as on August 11, 2026 at 10:36 pm IST.

How to invest in Generate Biomedicines Inc. Stock (GENB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Generate Biomedicines Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Generate Biomedicines Inc. Shares that will get you 0.1041 shares as per Generate Biomedicines Inc. share price of $14.41 per share as on August 11, 2026 at 10:36 pm IST.

What is the minimum amount required to buy Generate Biomedicines Inc. Stock (GENB) from India?

Indian investors can start investing in Generate Biomedicines Inc. (GENB) shares with as little as ₹95.435 or $1 (as of August 11, 2026 at 10:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹954.35 in Generate Biomedicines Inc. stock (as per the Rupee-Dollar exchange rate as on August 11, 2026 at 10:37 pm IST). Based on Generate Biomedicines Inc. share’s latest price of $14.41 as on August 11, 2026 at 10:36 pm IST, you will get 0.6940 shares of Generate Biomedicines Inc.. Learn more about fractional shares .